British data shows natural immunity as good or better than COVID vaccine

Recovering from Covid offers just as good protection as getting two doses of any vaccine, official figures suggest.

An Office for National Statistics’ (ONS) report published today found unvaccinated Britons who catch the Delta variant are around 71 per cent less likely to test positive for a second time.

It estimated the risk of infection is slashed by approximately 67 per cent in people given two doses of Pfizer or AstraZeneca‘s jabs.

The ONS said there was ‘no evidence’ vaccines offered more immunity than catching Covid itself, despite a number of other studies showing the opposite. 

The findings are based on more than 8,000 positive tests across Britain between May and August, when the Delta variant became dominant.

Scientists are still trying to untangle exactly how long naturally-acquired and vaccine immunity lasts.

Protection from the jabs appears to dip at around five months, which is why Britons over the age of 50 are being offered booster doses this autumn. But the duration of natural immunity remains somewhat of a mystery, made more complicated by the rise of new variants.

The above graph shows the risk of catching the virus by vaccination status and previous infection. It reveals that there is no difference in risk between the double-vaccinated and those who have previously recovered from infection (shown by the blue lines, which represent the variation between each result, overlapping)
When broken down by vaccine, Pfizer’s jab was slightly more effective than AstraZeneca’s

The ONS looked at 8,306 positive PCR results between May 17 and August 14.

Samples were collected from unvaccinated, fully vaccinated and double-jabbed volunteers, some who had previously had the virus already.

Using a statistical analysis, the report found those who were double-jabbed had a reduced the risk of testing positive by between 64 and 70 per cent, giving the headline figure of 67 per cent.

In people who were unvaccinated but previously positive, the risk was cut by between 65 per cent to 77 per cent.

The overlap in confidence intervals meant that there was no statistical difference between the results.

Writing in the report, the ONS said: ‘There was no evidence that the reduction in risk of infection from two vaccine doses differed from that of previous natural infection.

The ONS found that two doses of Pfizer’s jab offered slightly higher protection against infection than two of AstraZeneca.

Data from the ONS report also confirmed that the vaccines are less likely to stop an infection now than when the Alpha variant was dominant, between December 2020 and May this year.


Click this link for the original source of this article.
Author: ThinkCivics Newswire

This content is courtesy of, and owned and copyrighted by, and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact using the email address in the Contact page found in the website menu.

Inline Feedbacks
View all comments
A better search engine:
Another search engine:
Visit our forum at
Visit our store at

Follow us: